Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022
2022年1月6日 - 10:55PM
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the
“Company”), a specialty pharmaceutical company, announced today
that Brian Markison, Chief Executive Officer, James “JD” Schaub,
Chief Operating Officer, and other key speakers, will host a call
to discuss recent UPNEEQ
® trends, pending
expansion into the medical Aesthetics market and other general
business updates as follows:
Date: |
Wednesday,
January 19, 2022 |
Time: |
8:30 a.m. ET |
Webcast: |
https://experience.v-unite.com/#/aestheticrecorddemo/rvlinvestorday/room/welcome |
The webcast will be available thereafter via the Company’s
website at www.rvlpharma.com under the “Investor & News”
section.
About Osmotica Pharmaceuticals plcOsmotica
Pharmaceuticals plc (Nasdaq: OSMT) is a specialty pharmaceutical
company focused on the development and commercialization of
products that target markets with underserved patient populations.
RVL Pharmaceuticals, Inc., is the Company’s ophthalmic and medical
aesthetics subsidiary supporting UPNEEQ®.
Investor and Media Relations for
Osmotica Pharmaceuticals plcLisa M. WilsonIn-Site
Communications, Inc.T: 212-452-2793E: lwilson@insitecony.com
Osmotica Pharmaceuticals (NASDAQ:OSMT)
過去 株価チャート
から 11 2024 まで 12 2024
Osmotica Pharmaceuticals (NASDAQ:OSMT)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Osmotica Pharmaceuticals PLC (ナスダック市場): 0 recent articles
その他のニュース記事